Gofen & Glossberg’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Gofen & Glossberg’s Portfolio RNLX Stock Details RNLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$352K	Buy	188,224 +1,000	+0.5%	+$1.56K	0.01%	402
2022 Q3	$240K	Buy	187,224 +4,000	+2%	+$8.71K	0.01%	462
2022 Q2	$449K	Hold	183,224	–	–	0.01%	337
2022 Q1	$1.27M	Buy	183,224 +17,500	+11%	+$185K	0.03%	228
2021 Q4	$2.63M	Hold	165,724	–	–	0.06%	182
2021 Q3	$3.32M	Buy	165,724 +11,100	+7%	+$286K	0.08%	163
2021 Q2	$4.77M	Hold	154,624	–	–	0.11%	145
2021 Q1	$3.97M	Buy	154,624 +32,174	+26%	+$806K	0.1%	144
2020 Q4	$1.96M	Buy	122,450 +8,250	+7%	+$102K	0.05%	179
2020 Q3	$1.39M	Buy	+114,200	New	+$1.65M	0.04%	194

Other funds holding RNLX

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NSIM

North Star Investment Management Chicago, Illinois $1.65B AUM 20.56% 1-Year Est. Return

Gofen & Glossberg's RNLX Position: Q4 2022 in Review

Gofen & Glossberg increased its Renalytix plc American Depositary Shares (RNLX) stake by 0.53% in Q4 2022, buying an estimated $1.56K and bringing the position to 188,224 shares worth $352K. The position accounts for 0.01% of the portfolio, ranked #402.

Gofen & Glossberg first reported a position in RNLX in Q3 2020 and has held it in 10 quarters since. The position peaked at $4.77M in Q2 2021. 21 funds tracked by Wall St. Rank hold RNLX as of Q4 2022.

Gofen & Glossberg held 188,224 shares of Renalytix plc American Depositary Shares worth $352K as of Q4 2022.
Gofen & Glossberg bought 1,000 Renalytix plc American Depositary Shares shares in Q4 2022, an estimated $1.56K.
Renalytix plc American Depositary Shares made up 0.01% of Gofen & Glossberg's portfolio in Q4 2022, its #402 holding.
Gofen & Glossberg first reported a position in Renalytix plc American Depositary Shares in Q3 2020 and has held it in 10 quarters since.
Gofen & Glossberg's Renalytix plc American Depositary Shares position peaked at $4.77M in Q2 2021.
21 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q4 2022.

Based on Gofen & Glossberg's 13F filing for Q4 2022, filed 13 Jan 2023.